mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.09 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
-0.23 |
0.09 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.09 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.09 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.1 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.1 |